Compass Therapeutics (CMPX) FCF Margin (2024)
Historic FCF Margin for Compass Therapeutics (CMPX) over the last 1 years, with Q2 2024 value amounting to 1265.18%.
- Compass Therapeutics' FCF Margin changed N/A to 1265.18% in Q2 2024 from the same period last year, while for Mar 2025 it was 5204.35%, marking a year-over-year change of. This contributed to the annual value of 5282.24% for FY2024, which is N/A changed from last year.
- As of Q2 2024, Compass Therapeutics' FCF Margin stood at 1265.18%.
- Compass Therapeutics' FCF Margin's 5-year high stood at 1265.18% during Q2 2024, with a 5-year trough of 1265.18% in Q2 2024.